Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
February 14 2024 - 2:14PM
Edgar (US Regulatory)
CUSIP No: 59564R708
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED
PURSUANT
TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO FILED
PURSUANT TO § 240.13d-2.
(Amendment No. 1)*
Biodexa Pharmaceuticals
PLC
(formerly Midatech Pharma PLC)
(Name of Issuer)
Ordinary Shares, nominal value £0.001 per
share
(Title of Class of Securities)
59564R708
(CUSIP Number)
December 31, 2023
(Date of Event Which Requires Filing of this statement)
Check the appropriate box to designate the rule
pursuant to which this Schedule is filed:
¨ |
Rule 13d-1(b) |
x |
Rule 13d-1(c) |
¨ |
Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this
cover page shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
CUSIP No: 59564R708
(1) |
NAMES OF REPORTING
PERSONS
CVI Investments, Inc. |
|
(2) |
CHECK THE APPROPRIATE BOX IF A
MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
|
|
(a) ¨
(b) ¨ |
(3) |
SEC USE ONLY
|
|
(4) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands |
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
(5) |
SOLE VOTING POWER
0 |
(6) |
SHARED VOTING POWER **
0 |
(7) |
SOLE DISPOSITIVE POWER
0 |
(8) |
SHARED DISPOSITIVE POWER **
0 |
(9) |
AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON
0 |
|
(10) |
CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) |
|
|
|
¨ |
(11) |
PERCENT OF CLASS REPRESENTED BY
AMOUNT IN ROW (9)
0% |
|
(12) |
TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS)
CO |
|
** Heights Capital Management, Inc. is the investment manager to CVI
Investments, Inc. and as such may exercise voting and dispositive power over these shares.
CUSIP No: 59564R708
(1) |
NAMES OF REPORTING
PERSONS
Heights Capital Management, Inc. |
|
(2) |
CHECK THE APPROPRIATE BOX IF A
MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
|
|
(a) ¨
(b) ¨ |
(3) |
SEC USE ONLY
|
|
(4) |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH |
(5) |
SOLE VOTING POWER
0 |
(6) |
SHARED VOTING POWER **
0 |
(7) |
SOLE DISPOSITIVE POWER
0 |
(8) |
SHARED DISPOSITIVE POWER **
0 |
(9) |
AGGREGATE AMOUNT BENEFICIALLY
OWNED BY EACH REPORTING PERSON
0 |
|
(10) |
CHECK BOX IF THE AGGREGATE AMOUNT
IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) |
|
|
|
¨ |
(11) |
PERCENT OF CLASS REPRESENTED BY
AMOUNT IN ROW (9)
0% |
|
(12) |
TYPE
OF REPORTING PERSON (SEE INSTRUCTIONS)
CO |
|
** Heights Capital Management, Inc. is the investment manager to CVI
Investments, Inc. and as such may exercise voting and dispositive power over these shares.
CUSIP No: 59564R708
Item 1.
Biodexa Pharmaceuticals PLC (formerly Midatech Pharma PLC) (the “Company”)
| (b) | Address of Issuer’s Principal Executive Offices |
1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United
Kingdom
Item 2(a). |
Name of Person Filing |
This statement is filed by the entities listed below, who are collectively referred to herein as “Reporting Persons,” with
respect to the ordinary shares of the Company, nominal value £0.001 per share (the “Shares”).
| (ii) | Heights Capital Management, Inc. |
Item 2(b). |
Address of Principal Business Office or, if none, Residence |
The address of the principal business office of CVI Investments,
Inc. is:
P.O. Box 309GT
Ugland House
South Church Street
George Town
Grand Cayman
KY1-1104
Cayman Islands
The address of the principal business office of Heights Capital
Management, Inc. is:
101 California Street, Suite 3250
San Francisco, California 94111
Citizenship is set forth in Row 4 of the cover page for each
Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
Item 2(d) |
Title of Class of Securities |
Ordinary shares, nominal value £0.001 per share
59564R708. The CUSIP Number applies to the American Depositary Shares,
each of which represents four hundred (400) Shares.
CUSIP No: 59564R708
Item 3. | If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
(a) |
¨ |
Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). |
|
|
|
(b) |
¨ |
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). |
|
|
|
(c) |
¨ |
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). |
|
|
|
(d) |
¨ |
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). |
|
|
|
(e) |
¨ |
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E); |
|
|
|
(f) |
¨ |
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F); |
|
|
|
(g) |
¨ |
A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G); |
|
|
|
(h) |
¨ |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); |
|
|
|
(i) |
¨ |
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); |
|
|
|
(j) |
¨ |
A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J); |
|
|
|
(k) |
¨ |
Group, in accordance with Rule 13d-1(b)(1)(ii)(K). |
If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J),
please specify the type of institution: ________________
Provide the following information regarding the aggregate number
and percentage of the class of securities of the issuer identified in Item 1.
The information required by Items 4(a) – (c) is set
forth in Rows 5 – 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting
Person.
Heights Capital Management, Inc., which serves as the
investment manager to CVI Investments, Inc., may be deemed to be the beneficial owner of all Shares owned by CVI Investments, Inc.
Each of the Reporting Persons hereby disclaims any beneficial ownership of any such Shares, except for their pecuniary interest
therein.
Item 5. |
Ownership of Five Percent or Less of a Class |
If this statement is being filed to report the fact that as of the
date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the
following: x
Item 6. |
Ownership of More than Five Percent on Behalf of Another Person |
Not applicable.
CUSIP No: 59564R708
Item 7. |
Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding Company or Control Person |
Not applicable.
Item 8. |
Identification and Classification of Members of the Group |
Not applicable.
Item 9. |
Notice of Dissolution of Group |
Not applicable.
By signing below each of the undersigned certifies that, to the best
of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect
of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as
a participant in any transaction having that purpose or effect.
CUSIP No: 59564R708
SIGNATURES
After reasonable inquiry and to the best of its knowledge and
belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and
correct.
Dated: February 12, 2024
CVI INVESTMENTS, INC. |
|
HEIGHTS CAPITAL MANAGEMENT, INC. |
|
|
|
By: Heights Capital Management, Inc. |
|
By: |
/s/ Brian Sopinsky |
pursuant to a Limited Power of |
|
Name: |
Brian Sopinsky |
Attorney, a copy of which was |
|
Title: |
Secretary |
previously filed |
|
|
|
|
|
By: |
/s/ Brian Sopinsky |
|
|
|
Name: |
Brian Sopinsky |
|
|
Title: |
Secretary |
|
|
CUSIP No: 59564R708
EXHIBIT INDEX
EXHIBIT |
|
DESCRIPTION |
I |
|
Limited Power of Attorney* |
II |
|
Joint Filing Agreement* |
*Previously filed
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Apr 2023 to Apr 2024